Flu vaccine study reveals Nose's secret battle in COPD patients

NCT ID NCT04901455

First seen Feb 26, 2026 · Last updated May 21, 2026 · Updated 6 times

Summary

This study looked at how the nasal immune system responds to a live, weakened flu vaccine in 24 people with COPD. Researchers compared those who had frequent flare-ups (two or more in the past year) to those who did not. The goal was to understand differences in immune signals and virus growth in the nose, which may help explain why some people with COPD get sicker from the flu.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Eastowne Medical Office Building

    Chapel Hill, North Carolina, 27514, United States

Conditions

Explore the condition pages connected to this study.